01 July 2012: Basic Research
Altered expression of base excision repair genes in response to high glucose-induced oxidative stress in HepG2 hepatocytes
Jing Pang ABCDEFG , Chao Xi BCEFG , Yang Dai BC , Huan Gong BC , Tie-mei Zhang ADEFG
DOI: 10.12659/MSM.883206
Med Sci Monit 2012; 18(7): BR281-285
Background
Persistent hyperglycemia plays a major role in β-cell dysfunction and insulin resistance, which leads to the further progression of diabetes [1]. One potential central mechanism for hyperglycemia is the formation of excess reactive oxygen species (ROS) [2,3]. ROS accumulation leads to oxidative DNA damage, which is detected by several sensor proteins that activate DNA repair pathways [4,5]. Imperfections in DNA repair may induce changes in the genetic information, leading to cell death or disease, which implies that cell fate can be determined by the ability to repair DNA.
Diabetes-associated DNA damage has been widely described [6,7], and DNA repair mechanisms are initiated to counteract hyperglycemia-induced oxidative DNA damage [8]. Base excision repair (BER) is the major pathway involved in the repair of hyperglycemia-induced oxidative base modifications, which is different from the radiation-induced DNA repair system [9,10], depending on a series of enzymatic reactions. Several BER enzymes have been found to be related with diabetes. In the first step of the BER pathway, 8-oxoguanine DNA glycosylase (OGG1) recognizes and excises 8-hydroxylation of guanine bases (8-oxodG) [11]. The expression of OGG1 is significantly increased in the islets of patients with type 2 diabetes and positively correlates with disease progression [12]. Additionally, the activation of the DNA repair enzyme, poly(ADP-ribose) polymerase 1 (PARP1), is increased in diabetic patients compared to normal controls [13]. Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. While it is clear that hyperglycemia induces DNA damage via the production of ROS, the effect of hyperglycemia on DNA repair enzymes has not been investigated. We therefore investigated whether the BER enzymes
As hyperglycemia-induced cellular dysfunction accumulates
Material and Methods
CELL CULTURE:
Human hepatoma HepG2 cells were obtained from the Concord Cell Center (Peking Union Medical College, China) and were cultured in Eagle’s Minimum Essential Medium (MEM; Invitrogen, Carlsbad, CA) containing 5.5 mM glucose supplemented with 10% fetal bovine serum (Hyclone, Logan, UT). Cells were cultured in a 5% CO2-humidified atmosphere at 37°C. For high glucose treatment, the culture media was supplemented with 30 mM glucose.
MEASUREMENT OF INTRACELLULAR ROS GENERATION:
ROS determination was performed as previously described [14], based on the oxidation of the non-fluorescent DCFH (Beyotime, Shanghai, China) to the fluorescent dye 2′,7′-dichlorofluorescein (DCF) by peroxide. The intensity of fluorescence was immediately measured with flow cytometry (BD, Franklin Lakes, NJ) at an excitation of 488 nm and emission of 530 nm.
COMET ASSAY:
DNA damage was analyzed by the alkaline single-cell gel electrophoresis comet assay, as previously described [15]. The slides were observed under a microscope and the tail moment and olive tail moment were calculated from 100 randomly selected images from each sample using the CASP Comet Assay software.
QUANTITATIVE REAL-TIME PCR:
Total RNA was extracted from HepG2 cells using Trizol (Invitrogen), and cDNA was synthesized from 2 μg total RNA using M-MuLV reverse transcriptase (New England Biolabs, Beverly, MA). Real-time PCR was performed in a Lightcycler (Applied Biosystems, Foster City, CA) using the SYBR Green Master Mix Kit. PCR primers were constructed for ogg1, DNA polymerase beta (pol β), ligase III (lig3), X-ray repair cross complementing group 1 (xrcc1) and parp1, based on the published nucleotide sequences of human gene regions. A list of the PCR primers is shown in Table 1. Hprt served as an internal control, and the expression of the transcripts was quantified as a ratio of Hprt expression.
ESTIMATION OF NAD LEVELS:
Intracellular NAD content was measured using the NAD+/NADH quantification kit (k337; BioVision, Mountain View, CA) according to the manufacturer’s instructions.
WESTERN BLOT ANALYSIS:
Samples (50 μg protein) were separated by 9% SDS-PAGE, transferred to PVDF membrane and blocked with 5% milk in Tris-buffered saline with Tween (TBST). Samples were then incubated overnight at 4°C with antibodies for anti-poly(ADP-ribose) (PAR) (Trevigen, Gaithersburg, MD), anti-PARP1, anti-insulin receptor β (InsR β) or anti-phospho-InsR β (p-Tyr1150/1151-InsR) (Cell Signaling Technology, Danvers, MA). Bound antibodies were detected with HRP-linked secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA) and visualized using enhanced chemiluminescence. To determine if InsR was phosphorylated, we stimulated cells with 100 nM insulin for 20 min before lysis.
STATISTICAL ANALYSIS:
Data are expressed as mean ± standard deviation (SD). Comparisons between 2 means were performed using the independent-samples t-test; multiple comparisons amongst groups were analyzed using one-way ANOVA with SPSS software 11.0. Significance was defined as
Results
HIGH GLUCOSE CONCENTRATION INCREASES ROS GENERATION AND DNA DAMAGE:
No significant differences in ROS accumulation were observed in cells cultured with 5.5 mM glucose for 1, 2 or 4 days (Figure 1) or 24.5 mM-mannitol (permeability control). Extended exposure of HepG2 cells to 30 mM glucose induced ROS accumulation and DNA damage. Compared to 5.5 mM glucose-treated cells (control), 30 mM glucose led to a 3-fold increase in ROS accumulation at day 4 (Figure 1, p<0.05). Additionally, the extent of DNA damage, indicated by the olive tail moment and tail moment, was increased in cells treated with 30 mM glucose compared to cells treated with 5.5 mM glucose (Figure 2, p<0.05).
HIGH GLUCOSE CONCENTRATION INDUCES TRANSCRIPTION OF BER MRNAS:
The mRNA expression of BER proteins was examined in HepG2 cells cultured in 5.5 or 30 mM glucose for 1 to 4 days to assess how the DNA repair pathway responded to DNA damage during long-term high glucose treatment.
The expression of the mRNAs of BER genes did not significantly change in HepG2 cells cultured with 5.5 mM glucose at any time-point. In cells treated with high levels of glucose, the expression of ogg1 increased 1.8-fold at day 1, which then decreased after day 2, compared to cells cultured in 5.5 mM glucose (p<0.05, Figure 3A). In cells treated with 30 mM glucose, the expression of pol β increased at day 1 (2.7-fold) and day 2 (3.2-fold) and decreased after day 4, compared to cells treated with 5.5 mM glucose (p<0.05, Figure 3B). Lig3 mRNA expression increased over time in 30 mM glucose-treated cells, with a 2-fold increase observed day 4, compared to cells treated with 5.5 mM glucose (p<0.05, Figure 3C).
The mRNA expression levels of both parp1 and xrcc1 were higher in cells treated with 30 mM glucose compared to cells treated with 5.5 mM glucose from day 1 to day 4; however, these differences were not significant (Figure 3D, E).
HIGH GLUCOSE CONCENTRATION REDUCES INSULIN RECEPTOR PHOSPHORYLATION ACCOMPANIED BY PARP1 ACTIVATION AND CELLULAR NAD DEPLETION:
Since we have previously demonstrated that PARP1 activation modulates insulin sensitivity through NAD depletion [14], we examined the dynamic expression of PARP1 activity, intracellular NAD content and insulin receptor phosphorylation in high glucose concentrations. PARP1 protein expression was not significantly affected by high glucose (Figure 4A). We determined the total poly(ADP-ribosyl)ated protein content by Western blotting as a measure of PARP1 activity, and observed that PARP1 activity in 30 mM glucose-treated cells was approximately 2.2-fold higher than in 5.5 mM glucose-treated cells after day 6 (p<0.05, Figure 4B). Additionally, 30 mM glucose reduced the intracellular NAD content to approximately 50% of the NAD content in 5.5 mM glucose-treated cells at day 4 (p<0.05, Figure 4C). At day 2, 30 mM glucose had no significant effect on cellular NAD content and insulin receptor phosphorylation in response to insulin (Figure 4). However, insulin receptor phosphorylation was markedly attenuated after 4 days of treatment with 30 mM glucose (p<0.05, Figure 4D), which suggests that glucose toxicity accumulates gradually.
Discussion
The accumulation of oxidative damage as a result of chronic hyperglycemia is a causal link to tissue dysfunction in diabetes [16,17]. DNA oxidative damage can induce transcription and translation errors, which possibly contributed to pancreatic β-cell dysfunction and insulin resistance. Fortunately, the DNA repair system repairs the damaged DNA and maintains normal functions in cells. In this study we demonstrated that genes in the base excision repair pathway changed significantly in response to high glucose treatment, which contributed to altered DNA repair ability and genome stability.
ROS generation is a basic event in oxidative damage, so in the first part of this study we demonstrated that glucose intake caused a significant increase in ROS generation, which was consistent with a previous study by Mohanty [2]. However, in diabetes there are abnormalities of lipid metabolism and an increase in lipolysis, free fatty acid (FFA) concentrations and triglycerides. Several studies have demonstrated that an increase in FFA concentrations induces ROS generation, lipid peroxidation and inflammation [18,19]. Therefore, the oxidatively-mediated damage may be from a combination of hyperglycemia and elevated FFA concentrations. The source of ROS generation is an exciting focus in diabetes research, and deserves further investigation.
An increase in
We observed that the BER accessory protein mRNAs,
Conclusions
The altered expression of BER protein mRNAs in response to high glucose levels suggests functional roles for the BER repair system in genomic stability. In hyperglycemia, the accumulation of DNA damage due to the imbalance between DNA damage and repair may lead to further disease progression towards aggressive diabetes, which should be investigated in future studies. The altered expression of BER mRNAs may have potential as biomarkers to estimate disease progression in patients with diabetes.
References
1. Giaccari A, Sorice G, Muscogiuri G, Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes-mechanisms and potentials for treatment: Nutr Metab Cardiovasc Dis, 2009; 19; 365-77, pmid: 19428228
2. Mohanty P, Hamouda W, Garg R, Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes: J Clin Endocrinol Metab, 2000; 85; 2970-73, pmid: 10946914
3. Maiese K, Morhan SD, Chong ZZ, Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus: Curr Neurovasc Res, 2007; 4; 63-71, pmid: 17311546
4. Yang S, Chintapalli J, Sodagum L, Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination: Am J Physiol Renal Physiol, 2005; 289; 1144-52
5. Izumi T, Wiederhold LR, Roy G, Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage: Toxicology, 2003; 193; 43-65, pmid: 14599767
6. Dinçer Y, Akçay T, Alademir Z, Ilkova H, Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes: Mutat Res, 2002; 505; 75-81, pmid: 12175907
7. Anderson D, Yu TW, Wright J, Ioannides C, An examination of DNA strand breakage in the comet assay and antioxidant capacity in diabetic patients: Mutat Res, 1998; 398; 151-61, pmid: 9626975
8. Chen K, Yakes F, Srivastava D, Up-regulation of base excision repair correlates with enhanced protection against a DNA damaging agent in mouse cell lines: Nucleic Acids Research, 1998; 26; 2001-7, pmid: 9518496
9. Osley MA, Tsukuda T, Nickoloff JA, ATP-dependent chromatin remodeling factors and DNA damage repair: Mutat Res, 2007; 618; 65-80, pmid: 17291544
10. Li M, Wang W, Chen S, Radiation dose effect of DNA repair-related gene expression in mouse white blood cells: Med Sci Monit, 2011; 17(10); BR290-97, pmid: 21959603
11. Dandona P, Thusu K, Cook S, Oxidative damage to DNA in diabetes mellitus: Lancet, 1996; 347; 444-45, pmid: 8618487
12. Tyrberg B, Anachkov KA, Dib SA, Islet expression of the DNA repair enzyme 8-oxoguanosine DNA glycosylase (Ogg1) in human type 2 diabetes: BMC Endocr Disord, 2002; 2; 2, pmid: 12003641
13. Szabó C, Zanchi A, Komjati K, Poly(ADP-ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity: Circulation, 2002; 106; 2680-86, pmid: 12438293
14. Pang J, Gong H, Xi C, Poly(ADP-ribose) polymerase 1 is involved in glucose toxicity through SIRT1 modulation in HepG2 hepatocytes: J Cell Biochem, 2011; 112; 299-306, pmid: 21031461
15. Olive PL, Banáth JP, The comet assay: a method to measure DNA damage in individual cells: Nature Protocols, 2006; 1; 23-29, pmid: 17406208
16. Song F, Jia W, Yao Y, Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes: Clin Sci, 2007; 112; 599-606, pmid: 17209802
17. Golbidi S, Laher I, Antioxidant therapy in human endocrine disorders: Med Sci Monit, 2010; 16(1); RA9-24, pmid: 20037503
18. Mohanty P, Ghanim H, Hamouda W, Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells: Am J Clin Nutr, 2002; 75; 767-72, pmid: 11916766
19. Tripathy D, Mohanty P, Dhindsa S, Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects: Diabetes, 2003; 52; 2882-87, pmid: 14633847
20. Simone S, Gorin Y, Velagapudi C, Mechanism of oxidative DNA damage in diabetes: tuberin inactivation and downregulation of DNA repair enzyme 8-oxo-7,8-dihydro-2′-deoxyguanosine-DNA glycosylase: Diabetes, 2008; 57; 2626-36, pmid: 18599524
21. Rösen P, Nawroth PP, King G, The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society: Diabetes Metab Res Rev, 2001; 17; 189-212, pmid: 11424232
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






